Why is Kodiak Sciences stock rallying today?
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kodiak Sciences Inc (KOD)
Kodiak Sciences Inc stock price live, this page displays NASDAQ KOD stock exchange data. View the KOD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kodiak Sciences Inc real time stock price chart below.
What Is the Kodiak Sciences Inc Stock Price Today?
The Kodiak Sciences Inc stock price today is 98,460.
What Is the Stock Symbol for Kodiak Sciences Inc?
The stock symbol for Kodiak Sciences Inc is "KOD."
What Stock Exchange Does Kodiak Sciences Inc Trade On?
Kodiak Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Kodiak Sciences Inc a Good Stock to Buy?
Determining whether Kodiak Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KOD quote. (ISIN: US50015M1099)
What Is the Kodiak Sciences Inc Stock Price Today?
The Kodiak Sciences Inc stock price today is 98,460.
What Is the Stock Symbol for Kodiak Sciences Inc?
The stock symbol for Kodiak Sciences Inc is "KOD."
What Stock Exchange Does Kodiak Sciences Inc Trade On?
Kodiak Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Kodiak Sciences Inc a Good Stock to Buy?
Determining whether Kodiak Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KOD quote. (ISIN: US50015M1099)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
93.950
104.000
52 wk Range
10.940
104.000
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
93.950104.000
52 wk Range
10.940104.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KOD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
116.667
Upside
+18.49%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Why is Kodiak Sciences stock rallying today?
- Investing.com
Form 13D/A Kodiak Sciences Inc. For: 1 October- Investing.com
Form 4 Kodiak Sciences Inc For: 29 September- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 116.667
(+18.49% Upside)
Kodiak Sciences Inc SWOT Analysis
Pipeline Promise | Explore Kodiaq Sciences' diverse eye disease treatment portfolio, including KSI-101, tarcocimab, and KSI-501, with key trial results expected in 2025-2026 |
Financial Hurdles | Delve into the company's financial challenges, with negative EPS forecasts and a declining stock price, balanced against its cash-rich balance sheet |
Market Positioning | Learn how Kodiaq Sciences aims to differentiate itself in the competitive biotech sector through innovative treatments and a new wearable OCT device |
Future Outlook | Analyst price targets range from $3 to $4, reflecting cautious optimism amid clinical trial uncertainties and potential market opportunities |
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
-1,05 / -0,98
Revenue / Forecast
-- / --
Compare KOD to Peers and Sector
Metrics to compare | KOD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKODPeersSector | |
|---|---|---|---|---|
P/E Ratio | −25.5x | −1.6x | −0.3x | |
PEG Ratio | 2.43 | −0.05 | 0.00 | |
Price/Book | 101.1x | 3.6x | 2.6x | |
Price / LTM Sales | - | 89.2x | 3.0x | |
Upside (Analyst Target) | 23.1% | 277.5% | 56.4% | |
Fair Value Upside | Unlock | 0.8% | 7.2% | Unlock |
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company’s preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Kodiak Sciences (KOD) Stock Price Today?
The Kodiak Sciences stock price today is 98,460 USD.
What Stock Exchange Does Kodiak Sciences Trade On?
Kodiak Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Kodiak Sciences?
The stock symbol for Kodiak Sciences is "KOD."
What Is the Kodiak Sciences Market Cap?
As of today, Kodiak Sciences market cap is 5,950B USD.
What Is Kodiak Sciences's Earnings Per Share (TTM)?
The Kodiak Sciences EPS (TTM) is -4,176.
When Is the Next Kodiak Sciences Earnings Date?
Kodiak Sciences will release its next earnings report on Nov 12, 2026.
From a Technical Analysis Perspective, Is KOD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Kodiak Sciences Stock Split?
Kodiak Sciences has split 0 times.
How Many Employees Does Kodiak Sciences Have?
Kodiak Sciences has 141 employees.
What is the current trading status of Kodiak Sciences (KOD)?
As of Oct 02, 2026, Kodiak Sciences (KOD) is trading at a price of 98,460 USD, with a previous close of 94,800 USD. The stock has fluctuated within a day range of 93,950 USD to 104,000 USD, while its 52-week range spans from 10,940 USD to 103,919 USD.
What Is Kodiak Sciences (KOD) Price Target According to Analysts?
The average 12-month price target for Kodiak Sciences is 116,667 USD, with a high estimate of 145 USD and a low estimate of 96 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +18,49% Upside potential.
What Is the KOD Premarket Price?
KOD's last pre-market stock price is 94,400 USD. The pre-market share volume is 32 140,000, and the stock has decreased by -0,400, or -0,420%.
What Is the KOD After Hours Price?
KOD's last after hours stock price is 99,150 USD, the stock has decreased by 0,690, or 0,700%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.